Chronic ischemic mitral regurgitation

Area of Science:

• Cardiology
• Cardiac Surgery
• Echocardiography

Background:

• Ischemia-induced mitral insufficiency (IMI) is a complication of ischemic heart disease.
• Unlike organic mitral regurgitation, IMI does not involve structural damage to the mitral valve or subvalvular apparatus.
• Complex mechanisms involving left ventricular geometry, mitral annulus, papillary muscles, and hemodynamics contribute to IMI.

Purpose of the Study:

• To describe the mechanisms and assessment of ischemia-induced mitral insufficiency.
• To highlight the prognostic value of chronic IMI after myocardial infarction.
• To discuss current and developing therapeutic strategies for IMI.

Main Methods:

• Doppler echocardiography is the primary method for assessing IMI.
• Treadmill-exercise echocardiography is used to evaluate changes in regurgitant orifice area.
• Analysis of left ventricular geometry, mitral annulus, and papillary muscle dynamics.

Main Results:

• Regurgitant orifice area (ROA) > 20 mm² and resting regurgitated volume > 30 ml are adverse prognostic indicators.
• An increase in ROA > 13 mm² during exercise echocardiography predicts poor outcomes.
• Chronic IMI following infarction has a significant adverse prognostic value.

Conclusions:

• IMI is primarily driven by altered cardiac geometry and hemodynamics rather than papillary muscle dysfunction.
• Specific echocardiographic parameters (ROA, regurgitated volume) are crucial for predicting mortality in chronic IMI.
• Therapeutic interventions, including annuloplasty, are under development for managing IMI.